Cart (0 Items)
Your cart is currently empty.
View ProductsPerakizumab Biosimilar – Anti-IL17A mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Perakizumab Biosimilar - Anti-IL17A mAb - Research Grade |
|---|---|
| Source | CAS 1331830-76-2 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Perakizumab,RG4934,RO5310074,IL17A,anti-IL17A |
| Reference | PX-TA1301 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Perakizumab Biosimilar - Anti-IL17A mAb - Research Grade
General information on Anti-IL17A[Homo sapiens] (Perakizumab) Monoclonal Antibody
Perakizumab is humanized monoclonal antibody that targets IL17A. It has an immunomodulator activity and is used in the treatment of arthritis.
Related products
Antigen
Interleukin-17A(IL17A)
PX-P4824 210€
Antigen
IL17A, C-His, recombinant protein
PX-P5780 385€
SIL
Reviews
Il n’y a pas encore d’avis.